John Kenneth Hall
Affiliations: | 2010 | Molecular, Cellular and Developmental Biology | University of Colorado, Boulder, Boulder, CO, United States |
Google:
"John Hall"Mean distance: 17.91 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Bradley B. Olwin | grad student | 2010 | CU Boulder | |
| (Essential role of the satellite cell niche in skeletal muscle regeneration, aging, and disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Benasutti H, Maricelli JW, Seto J, et al. (2023) Efficacy and muscle safety assessment of fukutin-related protein gene therapy. Molecular Therapy. Methods & Clinical Development. 30: 65-80 |
| Desjardins CA, Yao M, Hall J, et al. (2022) Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice. Nucleic Acids Research |
| Kolwicz SC, Hall JK, Moussavi-Harami F, et al. (2019) Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate. Jacc. Basic to Translational Science. 4: 778-791 |
| Bengtsson NE, Hall JK, Odom GL, et al. (2017) Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 16007 |
| Hall MN, Hall JK, Cadwallader AB, et al. (2017) Transplantation of Skeletal Muscle Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1556: 237-244 |
| Bengtsson NE, Hall JK, Odom GL, et al. (2017) Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 14454 |
| Bengtsson NE, Hall JK, Odom GL, et al. (2016) 501. In Vivo Gene Editing for Duchenne Muscular Dystrophy Molecular Therapy. 24: S199 |
| Bengtsson NE, Seto JT, Hall JK, et al. (2015) Progress and prospects of gene therapy clinical trials for the muscular dystrophies. Human Molecular Genetics |
| Hall JK, Mozaffarian LL, Chamberlain JS. (2015) 617. Histologic Assessment of Geriatric Esophagus Revels Therapeutic Targets in Wild-Type and Dystrophic Mouse Models Molecular Therapy. 23: S245 |
| Bengtsson NE, Hall JK, Lieber AM, et al. (2015) 613. Characterization of IPSC-Derived Myogenic Progenitors Isolated from Mouse Models of Duchenne Muscular Dystrophy Molecular Therapy. 23: S243-S244 |